Grants per year
Personal profile
Research Interests
Pathogenesis & treatment of pituitary tumors, treatment of diabetic complications
Certifications and Licenses
| Internal Medicine | |
| Endocrinology, Diabetes & Metabolism |
Training Experience
| 1972 | Residency, Hospital of the University of Pennsylvania |
| 1975 | Fellowship, Univ. of CA-Los Angeles Med. Ctr. |
Education/Academic qualification
MD, University of Pennsylvania
… → 1969
Research interests
- Diabetes
- Endocrinology
- Medicine
- Metabolism
Fingerprint Dive into the research topics where Mark E Molitch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Prolactinoma
Medicine & Life Sciences
Pituitary Neoplasms
Medicine & Life Sciences
Prolactin
Medicine & Life Sciences
Type 1 Diabetes Mellitus
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Diabetic Nephropathies
Medicine & Life Sciences
Hyperprolactinemia
Medicine & Life Sciences
Insulin
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 1999 2024
Prot#CRN00808-03: An Open Label Exploratory Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly Treated with Somatostatin Analogue Based Treatment Regimens (ACROBAT EDGE)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
Prot#CRN00808-02: A Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly that are Responders to Octreotide Lar or Landreotide (ACROBAT EVOLVE)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
Prot#CLCI699C2X01B: An Open-label, Multi-Center, Roll-Over Study to Assess Long Term Safety in Patients with Endogenous Cushing’s Syndrome Who Have Completed a Prior Novartis-Sponsored Osilodrostat (LCI699) Study and are Judged by the Investigator to Bene
Novartis Pharmaceuticals Corporation
5/22/19 → 12/31/24
Project: Research project
Preventing Early Renal Loss Follow-up Study (PERLage)
Joslin Diabetes Center, Inc., JDRF International
5/16/19 → 10/31/20
Project: Research project
Prot#: ISIS 766720-CS2: A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of ISIS 766720 (IONIS GHR-LRX, an Antisense Inhibitor of the Growth Hormone Receptor) Administered Once Every 28 Days for 16 Weeks i
Medpace Clinical Research LLC, Ionis Pharmaceuticals, Inc.
4/3/19 → 4/3/22
Project: Research project
Research Output 1969 2020
Growth hormone replacement in adults: Real-world data from two large studies in US and Europe
Weber, M. M., Gordon, M. B., Höybye, C., Jørgensen, J. O. L., Puras, G., Popovic-Brkic, V., Molitch, M. E., Ostrow, V., Holot, N., Pietropoli, A. & Biller, B. M. K., Feb 2020, In : Growth Hormone and IGF Research. 50, p. 71-82 12 p.Research output: Contribution to journal › Article
Growth Hormone
Human Growth Hormone
Outcome Assessment (Health Care)
Safety
Waist Circumference
20
Citations
(Scopus)
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
Rangaswami, J., Bhalla, V., Blair, J. E. A., Chang, T. I., Costa, S., Lentine, K. L., Lerma, E. V., Mezue, K., Molitch, M., Mullens, W., Ronco, C., Tang, W. H. W. & Mccullough, P. A., Apr 16 2019, In : Circulation. 139, 16, p. E840-E878Research output: Contribution to journal › Article
Open Access
Cardio-Renal Syndrome
Kidney
Therapeutics
Palliative Care
Diabetes Mellitus
3
Citations
(Scopus)
Early glomerular hyperfiltration and long-term kidney outcomes in type 1 diabetes: The DCCT/EDIC experience
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Jun 7 2019, In : Clinical Journal of the American Society of Nephrology. 14, 6, p. 854-861 8 p.Research output: Contribution to journal › Article
Diabetes Complications
Type 1 Diabetes Mellitus
Diabetic Nephropathies
Iothalamic Acid
Kidney
Other pituitary disorders and kidney disease
Huang, W. & Molitch, M. E., Mar 13 2019, Endocrine Disorders in Kidney Disease: Diagnosis and Treatment. Springer International Publishing, p. 309-320 12 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
1
Citation
(Scopus)
Pituitary Tumors in Pregnancy
Huang, W. & Molitch, M. E., Sep 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 3, p. 569-581 13 p.Research output: Contribution to journal › Review article
Pituitary Neoplasms
Pregnancy
Pituitary Hormones
Prolactinoma
Pituitary ACTH Hypersecretion